Lung Cancer Essential Panel

Test Code
SLS162400

What is the Lung Cancer Essential Panel?

This panel analyzes mutations in 7 genes using DNA sequencing and fusions in 6 genes using RNA sequencing. It provides critical information for selecting targeted therapies and is often performed at the time of diagnosis.

Genes Covered/ No. of Genes: SNVs, InDels, CNVs covered for 7 genes (via DNA sequencing), Gene fusions covered in 6 genes (via RNA sequencing)

Who Is This Test For?

Patients diagnosed with non-small cell lung cancer, particularly those being evaluated for targeted therapy options.

Key Features

  • Covers 11 key genes in major lung cancer signaling pathways
  • Detects mutations in 7 genes using DNA sequencing and fusions in 6 genes using RNA sequencing, integrating DNA and RNA-based analysis for comprehensive profiling

Clinical Applications

  • Identifies actionable genetic alterations and gene fusions
  • Determines eligibility for targeted treatments, such as EGFR, ALK inhibitors, and supports precision oncology by aligning therapy with the tumor’s molecular profile

Contact Us